Modeling Stress-precipitated Smoking Behavior for Medication Development
Conditions
Smoking
What is the purpose of this trial?
The purpose of this study is to examine whether guanfacine or carvedilol will attenuate the ability of stress to precipitate smoking lapse behavior in treatment seeking and non-treatment seeking daily smokers. Participants seeking treatment for smoking will participate in a smoking cessation attempt after the laboratory sessions. Also looking at gender differences.
Participation Guidelines
- Age:
- 18 Years - 60 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- National Institute on Drug Abuse (NIDA)
Office of Research on Women's Health (ORWH)
Yale University - Dates:
- October 2008
- Last Updated:
- July 31, 2012
- Study HIC#:
- 0808004163
Clinicaltrials.gov ID: NCT00773357
